Fast Acting Mylanta (calcium carbonate / magnesium hydroxide) Drug Interactions
A total of 389 drugs are known to interact with Fast Acting Mylanta (calcium carbonate / magnesium hydroxide).
- 6 major drug interactions
- 325 moderate drug interactions
- 58 minor drug interactions
Check for interactions
Most frequently checked interactions
View interaction reports for Fast Acting Mylanta (calcium carbonate / magnesium hydroxide) and the medicines listed below.
- amlodipine
- Artificial Tears (ocular lubricant ophthalmic)
- aspirin
- atorvastatin
- Benadryl (diphenhydramine)
- cyclosporine ophthalmic
- docusate
- Eye Allergy Relief (naphazoline / pheniramine ophthalmic)
- guaifenesin
- Halls Mentho-Lyptus Drops (menthol topical)
- hydrogen peroxide topical
- Imodium (loperamide)
- Metoprolol Tartrate (metoprolol)
- Nature's Bounty Red Krill Oil (omega-3 polyunsaturated fatty acids)
- nifedipine
- potassium chloride
- simethicone
- Triple Antibiotic (bacitracin / neomycin / polymyxin b topical)
- Vaseline (petrolatum topical)
- Vicks VapoRub (camphor / eucalyptus / menthol topical)
Fast Acting Mylanta (calcium carbonate / magnesium hydroxide) alcohol/food interactions
There is 1 alcohol/food interaction with Fast Acting Mylanta (calcium carbonate / magnesium hydroxide)
Fast Acting Mylanta (calcium carbonate / magnesium hydroxide) disease interactions
There are 8 disease interactions with Fast Acting Mylanta (calcium carbonate / magnesium hydroxide) which include:
- phosphate calcifications
- cardiac contraction/conduction
- malabsorption
- renal dysfunction
- sarcoidosis
- inflammatory bowel disease
- intestinal obstruction disorders
- renal dysfunction
More about Fast Acting Mylanta (calcium carbonate / magnesium hydroxide)
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
